Maxolon and Pulmicort drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Maxolon (metoclopramide hydrochloride) and Pulmicort (budesonide). Common drug interactions include cellulitis among females and subdural haematoma among males.

The phase IV clinical study analyzes what interactions people have when they take Maxolon and Pulmicort. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Maxolon?

Maxolon has active ingredients of metoclopramide hydrochloride. It is often used in nausea. eHealthMe is studying from 1,977 Maxolon users. Check the latest studies of Maxolon.

What is Pulmicort?

Pulmicort has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 34,980 Pulmicort users. Check the latest studies of Pulmicort.

On Jul, 09, 2026

21 people who take Maxolon and Pulmicort together, and have interactions are studied.

Maxolon and Pulmicort drug interactions.

What are the common drug interactions of Maxolon and Pulmicort, by gender? *:

female:

Cellulitis (infection under the skin)
Dyspnoea (difficult or laboured respiration)
Retinal haemorrhage (bleeding from retina)
Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
Injection site inflammation
Localised oedema (fluid retention in a particular part of the body)
Lower respiratory tract infection
Drug hypersensitivity
Hepatic mass
Liver disorder (liver diseases)

male:

Subdural haematoma (blood collects between the skull and the surface of the brain)
Colitis (inflammation of colon)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Pneumonia
Premature baby
Pyrexia (fever)
Respiratory distress (difficulty in breathing)
Road traffic accident
Constipation
Cough

What are the common drug interactions of Maxolon and Pulmicort, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Cellulitis (infection under the skin)
Dyspnoea (difficult or laboured respiration)
Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
Injection site inflammation
Localised oedema (fluid retention in a particular part of the body)
Drug hypersensitivity
Oedema (fluid collection in tissue)
Similar reaction on previous exposure to drug
Abdominal distension
Disturbance in attention

40-49:

Hepatic mass
Liver disorder (liver diseases)
Lower respiratory tract infection
Gastrointestinal cancer metastatic (gastrointestinal tract cancer spreads to other organ)
Hepatic cancer metastatic (liver cancer - metastatic)
Metastatic neoplasm (spreadable cancer tumour)
Visual acuity reduced (reduced clearness of vision)
Retinal haemorrhage (bleeding from retina)

50-59:

Acute monocytic leukaemia (a type of blood cancer)
Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
Back pain
Contusion (a type of hematoma of tissue in which capillaries)
Pain in extremity
Rectal haemorrhage (bleeding from anus)

60+:

Subdural haematoma (blood collects between the skull and the surface of the brain)
Joint dislocation (a joint position is changed from normal position)
Road traffic accident

What are the existing conditions these people have? *

Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 9.52%
Salivary Hypersecretion (excess saliva secretion): 2 people, 9.52%
Leukaemia (blood or bone marrow cancer): 2 people, 9.52%
Breast Cancer: 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Maxolon and Pulmicort?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously